Table of Content
1 Market Overview
1.1 Nuclear Medicine/Radiopharmaceutic Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Nuclear Medicine/Radiopharmaceutic Market Size & Forecast
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Revenue (2019 VS 2023 VS 2030)
1.4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Nuclear Medicine/Radiopharmaceutic Market Drivers
1.5.2 Nuclear Medicine/Radiopharmaceutic Market Restraints
1.5.3 Nuclear Medicine/Radiopharmaceutic Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Business Overview
2.1.2 Bracco Imaging SWOT Analysis
2.1.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Products and Service Offered
2.1.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Revenue and Gross Margin
2.2 Bayer
2.2.1 Business Overview
2.2.2 Bayer SWOT Analysis
2.2.3 Bayer Nuclear Medicine/Radiopharmaceutic Products and Service Offered
2.2.4 Bayer Nuclear Medicine/Radiopharmaceutic Revenue and Gross Margin
2.3 Mallinckrodt
2.3.1 Business Overview
2.3.2 Mallinckrodt SWOT Analysis
2.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Products and Service Offered
2.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Revenue and Gross Margin
2.4 Nordion
2.4.1 Business Overview
2.4.2 Nordion SWOT Analysis
2.4.3 Nordion Nuclear Medicine/Radiopharmaceutic Products and Service Offered
2.4.4 Nordion Nuclear Medicine/Radiopharmaceutic Revenue and Gross Margin
2.5 Triad Isotopes
2.5.1 Business Overview
2.5.2 Triad Isotopes SWOT Analysis
2.5.3 Triad Isotopes Nuclear Medicine/Radiopharmaceutic Products and Service Offered
2.5.4 Triad Isotopes Nuclear Medicine/Radiopharmaceutic Revenue and Gross Margin
2.6 Lantheus
2.6.1 Business Overview
2.6.2 Lantheus SWOT Analysis
2.6.3 Lantheus Nuclear Medicine/Radiopharmaceutic Products and Service Offered
2.6.4 Lantheus Nuclear Medicine/Radiopharmaceutic Revenue and Gross Margin
2.7 IBA Group
2.7.1 Business Overview
2.7.2 IBA Group SWOT Analysis
2.7.3 IBA Group Nuclear Medicine/Radiopharmaceutic Products and Service Offered
2.7.4 IBA Group Nuclear Medicine/Radiopharmaceutic Revenue and Gross Margin
2.8 GE Healthcare
2.8.1 Business Overview
2.8.2 GE Healthcare SWOT Analysis
2.8.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products and Service Offered
2.8.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Revenue and Gross Margin
2.9 China Isotope & Radiation
2.9.1 Business Overview
2.9.2 China Isotope & Radiation SWOT Analysis
2.9.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Products and Service Offered
2.9.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Revenue and Gross Margin
2.10 Jubilant Pharma
2.10.1 Business Overview
2.10.2 Jubilant Pharma SWOT Analysis
2.10.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Products and Service Offered
2.10.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Revenue and Gross Margin
2.11 Eli Lilly
2.11.1 Business Overview
2.11.2 Eli Lilly SWOT Analysis
2.11.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Products and Service Offered
2.11.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Revenue and Gross Margin
3 Global Nuclear Medicine/Radiopharmaceutic Market Competition, by Manufacturer
3.1 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Nuclear Medicine/Radiopharmaceutic Players Market Share in 2023
3.2.2 Top 6 Nuclear Medicine/Radiopharmaceutic Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Nuclear Medicine/Radiopharmaceutic Players Head Office, Business Provided
3.4 Nuclear Medicine/Radiopharmaceutic Mergers & Acquisitions
3.5 Nuclear Medicine/Radiopharmaceutic New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Nuclear Medicine/Radiopharmaceutic Revenue in Value by Type (2019-2030)
4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global Nuclear Medicine/Radiopharmaceutic Revenue by Application (2019-2030)
5.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Application (2019-2030)
6 Global Nuclear Medicine/Radiopharmaceutic Market Analysis by Regions
6.1 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Regions
6.1.1 Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions (2019-2030)
6.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions (2019-2030)
6.2 North America Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
6.3 Europe Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
6.4 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
6.5 South America Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
6.6 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
7 North America Nuclear Medicine/Radiopharmaceutic by Country, by Type, and by Application
7.1 North America Nuclear Medicine/Radiopharmaceutic Revenue by Type (2019-2030)
7.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Application (2019-2030)
7.3 North America Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Countries
7.3.1 North America Nuclear Medicine/Radiopharmaceutic Revenue in Value by Country (2019-2030)
7.3.2 United States Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
7.3.3 Canada Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
7.3.4 Mexico Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Nuclear Medicine/Radiopharmaceutic by Country, by Type, and by Application
8.1 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Type (2019-2030)
8.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Application (2019-2030)
8.3 Europe Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Countries
8.3.1 Europe Nuclear Medicine/Radiopharmaceutic Revenue in Value by Country (2019-2030)
8.3.2 Germany Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
8.3.3 France Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
8.3.4 United Kingdom Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
8.3.5 Russia Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
8.3.6 Italy Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
8.3.7 Nordic Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Country, by Type, and by Application
9.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Type (2019-2030)
9.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Application (2019-2030)
9.3 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Countries
9.3.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue in Value by Country (2019-2030)
9.3.2 China Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
9.3.3 Japan Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
9.3.4 Korea Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
9.3.5 India Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
9.3.6 Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
9.3.7 Australia Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Nuclear Medicine/Radiopharmaceutic by Country, by Type, and by Application
10.1 South America Nuclear Medicine/Radiopharmaceutic Revenue by Type (2019-2030)
10.2 South America Nuclear Medicine/Radiopharmaceutic Revenue by Application (2019-2030)
10.3 South America Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Countries
10.3.1 South America Nuclear Medicine/Radiopharmaceutic Revenue in Value by Country (2019-2030)
10.3.2 Brazil Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
10.3.3 Argentina Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Nuclear Medicine/Radiopharmaceutic by Country, by Type, and by Application
11.1 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Type (2019-2030)
11.2 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Application (2019-2030)
11.3 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Countries
11.3.1 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue in Value by Country (2019-2030)
11.3.2 Turkey Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
11.3.3 Egypt Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
11.3.5 UAE Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
11.3.6 South Africa Nuclear Medicine/Radiopharmaceutic Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Nuclear Medicine/Radiopharmaceutic Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer